Beckley Psytech is dedicated to helping patients suffering from neurological and psychiatric disorders by developing a pipeline of psychedelic compounds into licensed pharmaceutical medicines. They are looking for universities that are working on serotonin (5HT2A) receptor agonists to elicit psychedelic effects, neuroplasticity, and neurogenesis.
Approaches of Interest
- Therapeutic approaches to treat disorders where there is a significant unmet need e.g., depression, addiction
- Therapeutic compounds with a suitable onset of action and duration of effect ...